首页 > 最新文献

AJOG global reports最新文献

英文 中文
Application of 4 birthweight curves and local reference range at a University Hospital of Rio de Janeiro, Brazil 巴西里约热内卢一所大学医院对四条出生体重曲线和当地参考范围的应用
Pub Date : 2024-03-10 DOI: 10.1016/j.xagr.2024.100336
Fabio G. Da Matta MD, MSc , Karina Bilda de Castro Rezende MD, PhD , Maria Isabel M.P. Cardoso MD, MSc , Luiza P. Ladeira MD , Rita G. Bornia MD, PhD , Joffre Amim Jr. MD, PhD

BACKGROUND

Numerous fetal growth curves have been developed from various subpopulations and geographic locations worldwide.

OBJECTIVE

To determine the birthweight standard at the Maternity School and compare it to currently used standards in the clinical practice services.

STUDY DESIGN

Cross-sectional, observational, and descriptive study. Data from infants born between 2011 and 2016 were collected from the Maternity School Hospital of the Federal University of Rio de Janeiro to define the 10th, 25th, 50th, 75th, and 90th percentiles of the birthweight by gestational age. It was determined the performance of the INTERGROWTH-21st, Fenton, Alexander, and Lubchenco for the Maternity School standards.

RESULTS

After the 33rd week of pregnancy, the INTERGROWTH standard was similar to the local standard for small-for-gestational-age infants and Fenton for large-for-gestational-age infants at Maternity School Hospital. The INTERGROWTH standard was found to be inadequate to classify small-for-gestational-age infants, which are babies at major risk for morbidity and mortality at the onset of the 33rd week of pregnancy.

CONCLUSION

It was possible to define reference values for birthweight for the maternal school hospital considering at least 33 weeks of pregnancy with a 95% confidence interval. The comparison of the INTERGROWTH, Fenton, Alexander, and Lubchenko standards to the maternal school hospital curve showed that the Fenton curve was the most suitable for the diagnosis of small for gestational age.

研究设计横断面、观察性和描述性研究。从里约热内卢联邦大学妇产学校医院收集了 2011 年至 2016 年间出生的婴儿数据,以确定胎龄出生体重的第 10、25、50、75 和 90 百分位数。结果在怀孕第 33 周后,INTERGROWTH 标准与孕龄小婴儿的当地标准相似,孕龄大婴儿的当地标准与 Fenton 标准相似。INTERGROWTH标准不足以对小于胎龄儿进行分类,而小于胎龄儿是指在妊娠第33周开始时就面临重大发病和死亡风险的婴儿。将 INTERGROWTH、Fenton、Alexander 和 Lubchenko 标准与孕产妇学校医院曲线进行比较后发现,Fenton 曲线最适合用于诊断小于胎龄儿。
{"title":"Application of 4 birthweight curves and local reference range at a University Hospital of Rio de Janeiro, Brazil","authors":"Fabio G. Da Matta MD, MSc ,&nbsp;Karina Bilda de Castro Rezende MD, PhD ,&nbsp;Maria Isabel M.P. Cardoso MD, MSc ,&nbsp;Luiza P. Ladeira MD ,&nbsp;Rita G. Bornia MD, PhD ,&nbsp;Joffre Amim Jr. MD, PhD","doi":"10.1016/j.xagr.2024.100336","DOIUrl":"10.1016/j.xagr.2024.100336","url":null,"abstract":"<div><h3>BACKGROUND</h3><p>Numerous fetal growth curves have been developed from various subpopulations and geographic locations worldwide.</p></div><div><h3>OBJECTIVE</h3><p>To determine the birthweight standard at the Maternity School and compare it to currently used standards in the clinical practice services.</p></div><div><h3>STUDY DESIGN</h3><p>Cross-sectional, observational, and descriptive study. Data from infants born between 2011 and 2016 were collected from the Maternity School Hospital of the Federal University of Rio de Janeiro to define the 10th, 25th, 50th, 75th, and 90th percentiles of the birthweight by gestational age. It was determined the performance of the INTERGROWTH-21st, Fenton, Alexander, and Lubchenco for the Maternity School standards.</p></div><div><h3>RESULTS</h3><p>After the 33rd week of pregnancy, the INTERGROWTH standard was similar to the local standard for small-for-gestational-age infants and Fenton for large-for-gestational-age infants at Maternity School Hospital. The INTERGROWTH standard was found to be inadequate to classify small-for-gestational-age infants, which are babies at major risk for morbidity and mortality at the onset of the 33rd week of pregnancy.</p></div><div><h3>CONCLUSION</h3><p>It was possible to define reference values for birthweight for the maternal school hospital considering at least 33 weeks of pregnancy with a 95% confidence interval. The comparison of the INTERGROWTH, Fenton, Alexander, and Lubchenko standards to the maternal school hospital curve showed that the Fenton curve was the most suitable for the diagnosis of small for gestational age.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000303/pdfft?md5=d914c39be7b03c836a4ad3efd7e5a78f&pid=1-s2.0-S2666577824000303-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140275518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of aspartate aminotransferase to Platelet Ratio Index and Fibrosis-4 Index score on women with intrahepatic cholestasis of pregnancy 评估妊娠期肝内胆汁淤积症妇女的 apri 和 fib-4 评分
Pub Date : 2024-03-10 DOI: 10.1016/j.xagr.2024.100337
Maria Cemortan PhD, Corina Iliadi-Tulbure PhD, Irina Sagaidac PhD, Olga Cernetchi PhD

BACKGROUND

Intrahepatic cholestasis of pregnancy is a pregnancy-related liver condition that is characterized by elevated liver function tests and/or bile acids in the presence of pruritis.

OBJECTIVE

The study aimed to assess the aspartate aminotransferase to Platelet Ratio Index and Fibrosis-4 Index scores in intrahepatic cholestasis of pregnancy.

STUDY DESIGN

The prospective study was carried out by assessing 142 women: 71 whose pregnancies were complicated by intrahepatic cholestasis of pregnancy and 71 without intrahepatic cholestasis of pregnancy. The Fibrosis-4 Index score and aspartate aminotransferase to Platelet Ratio Index were assessed.

RESULTS

Our findings indicate that both aspartate aminotransferase to Platelet Ratio Index and Fibrosis-4 Index scores were reliable indicators of intrahepatic cholestasis of pregnancy, correlating with important complications of the condition.

CONCLUSION

This study provides valuable information to help clinicians better diagnose and perform the management of intrahepatic cholestasis of pregnancy.

背景妊娠期肝内胆汁淤积症是一种与妊娠有关的肝脏疾病,其特点是肝功能检查和/或胆汁酸升高并伴有瘙痒。研究设计这项前瞻性研究对 142 名妇女进行了评估,其中 71 名妇女的妊娠合并有妊娠期肝内胆汁淤积症,71 名妇女没有妊娠期肝内胆汁淤积症。结果我们的研究结果表明,天门冬氨酸氨基转移酶与血小板比值指数和纤维化-4指数评分都是妊娠期肝内胆汁淤积症的可靠指标,与病情的重要并发症相关。
{"title":"Assessment of aspartate aminotransferase to Platelet Ratio Index and Fibrosis-4 Index score on women with intrahepatic cholestasis of pregnancy","authors":"Maria Cemortan PhD,&nbsp;Corina Iliadi-Tulbure PhD,&nbsp;Irina Sagaidac PhD,&nbsp;Olga Cernetchi PhD","doi":"10.1016/j.xagr.2024.100337","DOIUrl":"10.1016/j.xagr.2024.100337","url":null,"abstract":"<div><h3>BACKGROUND</h3><p>Intrahepatic cholestasis of pregnancy is a pregnancy-related liver condition that is characterized by elevated liver function tests and/or bile acids in the presence of pruritis.</p></div><div><h3>OBJECTIVE</h3><p>The study aimed to assess the aspartate aminotransferase to Platelet Ratio Index and Fibrosis-4 Index scores in intrahepatic cholestasis of pregnancy.</p></div><div><h3>STUDY DESIGN</h3><p>The prospective study was carried out by assessing 142 women: 71 whose pregnancies were complicated by intrahepatic cholestasis of pregnancy and 71 without intrahepatic cholestasis of pregnancy. The Fibrosis-4 Index score and aspartate aminotransferase to Platelet Ratio Index were assessed.</p></div><div><h3>RESULTS</h3><p>Our findings indicate that both aspartate aminotransferase to Platelet Ratio Index and Fibrosis-4 Index scores were reliable indicators of intrahepatic cholestasis of pregnancy, correlating with important complications of the condition.</p></div><div><h3>CONCLUSION</h3><p>This study provides valuable information to help clinicians better diagnose and perform the management of intrahepatic cholestasis of pregnancy.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000315/pdfft?md5=f306a331de17ab4391057bc4c5aa0036&pid=1-s2.0-S2666577824000315-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use patterns of a food referral program for pregnant individuals: findings from the Mid-Ohio Farmacy 孕妇食品转介计划的使用模式:中俄亥俄州农场的调查结果
Pub Date : 2024-03-10 DOI: 10.1016/j.xagr.2024.100338
Daniel M. Walker PhD, MPH, Jennifer A. Garner PhD, RD, Joshua J. Joseph MD, MPH, Jiqiang Wu MSc, Amy Headings PhD, RD, LD, Aaron Clark DO, Kartik K. Venkatesh MD, PhD
{"title":"Use patterns of a food referral program for pregnant individuals: findings from the Mid-Ohio Farmacy","authors":"Daniel M. Walker PhD, MPH,&nbsp;Jennifer A. Garner PhD, RD,&nbsp;Joshua J. Joseph MD, MPH,&nbsp;Jiqiang Wu MSc,&nbsp;Amy Headings PhD, RD, LD,&nbsp;Aaron Clark DO,&nbsp;Kartik K. Venkatesh MD, PhD","doi":"10.1016/j.xagr.2024.100338","DOIUrl":"https://doi.org/10.1016/j.xagr.2024.100338","url":null,"abstract":"","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000327/pdfft?md5=50804ad812584eb680cc94fa90d3263e&pid=1-s2.0-S2666577824000327-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140191148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in racial/ethnic disparities in postpartum hospital readmissions in California from 1997 to 2018 1997-2018 年加利福尼亚州产后再入院的种族/民族差异趋势。
Pub Date : 2024-03-10 DOI: 10.1016/j.xagr.2024.100331
Curisa M. Tucker PhD, RN , Chen Ma MS , Mahasin S. Mujahid PhD, MS, FAHA , Alexander J. Butwick MBBS, FRCA, MS , Anna I. Girsen MD, PhD , Ronald S. Gibbs MD , Suzan L. Carmichael PhD, MS

BACKGROUND

Postpartum readmission is an important indicator of postpartum morbidity. The likelihood of postpartum readmission is highest for Black individuals. However, it is unclear whether the likelihood of postpartum readmission has changed over time according to race/ethnicity. Little is also known about the factors that contribute to these trends.

OBJECTIVE

This study aimed to: (1) examine trends in postpartum readmission by race/ethnicity, (2) examine if prenatal or clinical factors explain the trends, and (3) investigate if racial/ethnic disparities changed over time.

STUDY DESIGN

We examined trends in postpartum readmission, defined as hospitalization within 42 days after birth hospitalization discharge, using live birth and fetal death certificates linked to delivery discharge records from 10,711,289 births in California from 1997 to 2018. We used multivariable logistic regression models that included year and year-squared (to allow for nonlinear trends), overall and stratified by race/ethnicity, to estimate the annual change in postpartum readmission during the study period, represented by odds ratios and 95% confidence intervals. We then adjusted models for prenatal (eg, patient demographics) and clinical (eg, gestational age, mode of birth) factors. To determine whether racial/ethnic disparities changed over time, we calculated risk ratios for 1997 and 2018 by comparing the predicted probabilities from the race-specific, unadjusted logistic regression models.

RESULTS

The overall incidence of postpartum readmission was 10 per 1000 births (17.4/1000 births for non-Hispanic Black, 10/1000 for non-Hispanic White, 7.9/1000 for non-Hispanic Asian/Pacific Islander, and 9.6/1000 for Hispanic individuals). Odds of readmission increased for all groups during the study period; the increase was greatest for Black individuals (42% vs 21%–29% for the other groups). After adjustment for prenatal and clinical factors, the increase in odds was similar for Black and White individuals (12%). The disparity in postpartum readmission rates relative to White individuals increased for Black individuals (risk ratio, 1.68 in 1997 and 1.90 in 2018) and more modestly for Hispanic individuals (risk ratio, 1.02 in 1997 and 1.05 in 2018) during the study period. Asian/Pacific Islander individuals continued to have lower risk than White individuals during the study period (risk ratio, 0.87 in 1997 and 0.82 in 2018).

CONCLUSION

The rate of postpartum readmissions increased from 1997 to 2018 in California across all racial/ethnic groups, with the greatest increase observed for Black individuals. Racial/ethnic differences in the trend were more modest after adjustment for prenatal and clinical factors. It is important to find ways to prevent further increases in postpartum readmission, especially among groups at highest risk.

背景产后再入院是产后发病率的一个重要指标。黑人产后再入院的可能性最大。然而,目前还不清楚产后再入院的可能性是否随着种族/族裔的不同而发生变化。本研究旨在(研究设计我们使用活产和胎儿死亡证明与加利福尼亚州 1997 年至 2018 年期间 10,711,289 例新生儿的分娩出院记录相连接,研究了产后再入院(定义为分娩住院出院后 42 天内住院)的趋势。我们使用包含年份和年份平方(以考虑非线性趋势)的多变量逻辑回归模型,按种族/族裔进行总体和分层,以估计研究期间产后再入院的年度变化,用几率比和 95% 置信区间表示。然后,我们根据产前因素(如患者人口统计学特征)和临床因素(如胎龄、分娩方式)对模型进行了调整。为了确定种族/族裔差异是否随时间推移而改变,我们通过比较种族特异性、未调整的逻辑回归模型的预测概率,计算了 1997 年和 2018 年的风险比。结果产后再入院的总发生率为每 1000 例新生儿中有 10 例(非西班牙裔黑人为 17.4/1000 例,非西班牙裔白人为 10/1000 例,非西班牙裔亚洲/太平洋岛民为 7.9/1000 例,西班牙裔个人为 9.6/1000 例)。在研究期间,所有群体的再入院几率都有所增加;其中黑人的增幅最大(42%,其他群体为 21%-29%)。在对产前和临床因素进行调整后,黑人和白人的再次入院几率增幅相似(12%)。在研究期间,黑人产后再入院率相对于白人的差距有所扩大(风险比,1997 年为 1.68,2018 年为 1.90),西班牙裔人的差距较小(风险比,1997 年为 1.02,2018 年为 1.05)。在研究期间,亚洲/太平洋岛民的风险仍然低于白人(风险比,1997 年为 0.87,2018 年为 0.82)。结论从 1997 年到 2018 年,加利福尼亚州所有种族/族裔群体的产后再入院率都有所上升,黑人的上升幅度最大。在对产前和临床因素进行调整后,种族/人种间的趋势差异较为温和。找到防止产后再入院进一步增加的方法非常重要,尤其是在风险最高的群体中。
{"title":"Trends in racial/ethnic disparities in postpartum hospital readmissions in California from 1997 to 2018","authors":"Curisa M. Tucker PhD, RN ,&nbsp;Chen Ma MS ,&nbsp;Mahasin S. Mujahid PhD, MS, FAHA ,&nbsp;Alexander J. Butwick MBBS, FRCA, MS ,&nbsp;Anna I. Girsen MD, PhD ,&nbsp;Ronald S. Gibbs MD ,&nbsp;Suzan L. Carmichael PhD, MS","doi":"10.1016/j.xagr.2024.100331","DOIUrl":"10.1016/j.xagr.2024.100331","url":null,"abstract":"<div><h3>BACKGROUND</h3><p>Postpartum readmission is an important indicator of postpartum morbidity. The likelihood of postpartum readmission is highest for Black individuals. However, it is unclear whether the likelihood of postpartum readmission has changed over time according to race/ethnicity. Little is also known about the factors that contribute to these trends.</p></div><div><h3>OBJECTIVE</h3><p>This study aimed to: (1) examine trends in postpartum readmission by race/ethnicity, (2) examine if prenatal or clinical factors explain the trends, and (3) investigate if racial/ethnic disparities changed over time.</p></div><div><h3>STUDY DESIGN</h3><p>We examined trends in postpartum readmission, defined as hospitalization within 42 days after birth hospitalization discharge, using live birth and fetal death certificates linked to delivery discharge records from 10,711,289 births in California from 1997 to 2018. We used multivariable logistic regression models that included year and year-squared (to allow for nonlinear trends), overall and stratified by race/ethnicity, to estimate the annual change in postpartum readmission during the study period, represented by odds ratios and 95% confidence intervals. We then adjusted models for prenatal (eg, patient demographics) and clinical (eg, gestational age, mode of birth) factors. To determine whether racial/ethnic disparities changed over time, we calculated risk ratios for 1997 and 2018 by comparing the predicted probabilities from the race-specific, unadjusted logistic regression models.</p></div><div><h3>RESULTS</h3><p>The overall incidence of postpartum readmission was 10 per 1000 births (17.4/1000 births for non-Hispanic Black, 10/1000 for non-Hispanic White, 7.9/1000 for non-Hispanic Asian/Pacific Islander, and 9.6/1000 for Hispanic individuals). Odds of readmission increased for all groups during the study period; the increase was greatest for Black individuals (42% vs 21%–29% for the other groups). After adjustment for prenatal and clinical factors, the increase in odds was similar for Black and White individuals (12%). The disparity in postpartum readmission rates relative to White individuals increased for Black individuals (risk ratio, 1.68 in 1997 and 1.90 in 2018) and more modestly for Hispanic individuals (risk ratio, 1.02 in 1997 and 1.05 in 2018) during the study period. Asian/Pacific Islander individuals continued to have lower risk than White individuals during the study period (risk ratio, 0.87 in 1997 and 0.82 in 2018).</p></div><div><h3>CONCLUSION</h3><p>The rate of postpartum readmissions increased from 1997 to 2018 in California across all racial/ethnic groups, with the greatest increase observed for Black individuals. Racial/ethnic differences in the trend were more modest after adjustment for prenatal and clinical factors. It is important to find ways to prevent further increases in postpartum readmission, especially among groups at highest risk.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266657782400025X/pdfft?md5=96c1f1bdc0b8fe1f083a26e2dbbca7a6&pid=1-s2.0-S266657782400025X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140281633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing trainee mistakes. Better performance with changing to a high-fidelity simulation system? 减少学员失误。改用高仿真模拟系统后性能更佳?
Pub Date : 2024-02-29 DOI: 10.1016/j.xagr.2024.100326
Aino Ritva Weyers , Gabriel von Waldenfels MD , Pimrapat Gebert PhD , Wolfgang Henrich MD, PhD , Larry Hinkson MBBS, MD, MRCOG, FRCOG

BACKGROUND

Postpartum hemorrhage is a significant cause of both maternal morbidity and mortality worldwide and is increasing in incidence. This study aimed to assess improvement and identify shortcomings in trainee performance in different simulation systems in the management of postpartum hemorrhage.

OBJECTIVE

To perform a pilot study evaluating and comparing high- and low-fidelity simulation models, assessing improvement in repeated performance with high-fidelity mode and identifying mistakes made assessed using Objective Structured Assessment of Technical Skills and thereby exploring what aspects of emergency management of postpartum hemorrhage should be prioritized in teaching settings and assessing what simulation setup is most effective in achieving competence.

STUDY DESIGN

This was a prospective randomized, single-blinded, single-institution trial in a population of 17 junior obstetrical trainees at the Charité University Hospital Obstetric Simulation Center in Berlin. Trainees were randomized into 2 groups, with either initial low-fidelity simulation or high-fidelity simulation, followed by repeated assessment of performance, using the high-fidelity model simulation system. Individual simulation sessions were video-recorded and transcribed, and the timing of interventions was documented. Strandardized Objective Structured Assessment of Technical Skills forms were used as a checklist for performance.

RESULTS

There was a statistically significant general improvement in performance (P=.02; 24.7–27.2 of 31.0 points; average of 8.7%) in the second cycle of simulation assessment and a statistically significant training effect (P=.043; 24.4–28.4 of 31.0 points; average of 12.9%) in the group that underwent repeat simulation assessment from the initial low-fidelity system to the high-fidelity system compared with the group using the same high-fidelity setup (P=.276; 25.0–25.8 of 31.0; average of 2.4%).

CONCLUSION

There was an improvement in the performance when trainees underwent a repeated cycle of simulation assessment changing from a low-fidelity system to a high-fidelity system. Simulation assessment can identify mistakes and learning gaps that are important for obstetrical trainees. This study found that trainees make the same mistakes, regardless of which simulation model was initially used.

背景产后出血是全球孕产妇发病率和死亡率的重要原因之一,且发病率不断上升。本研究旨在评估受训者在不同模拟系统中处理产后出血表现的改善情况并找出不足之处。目的开展一项试点研究,评估并比较高保真和低保真模拟模型,评估高保真模式下重复表现的改善情况,并通过客观结构化技术技能评估找出所犯的错误,从而探讨在教学环境中应优先考虑产后出血紧急处理的哪些方面,并评估哪种模拟设置最能有效提高能力。研究设计这是一项前瞻性随机、单盲、单机构试验,对象是柏林夏里特大学医院产科模拟中心的 17 名初级产科受训人员。受训者被随机分为两组,一组进行初始低保真模拟,另一组进行高保真模拟,然后使用高保真模型模拟系统对受训者的表现进行反复评估。对每个模拟课程进行了录像和转录,并记录了干预的时间。结果在第二轮模拟评估中,表现有了显著提高(P=.02;31.0 分中的 24.7-27.2;平均 8.7%),培训效果有显著提高(P=.043;31.0 分中的 24.4-28.4;平均 12.9%)。结论当学员接受从低保真系统到高保真系统的重复周期模拟评估时,他们的表现有所改善。模拟评估可以发现错误和学习差距,这对产科学员非常重要。本研究发现,无论最初使用哪种模拟模型,学员都会犯同样的错误。
{"title":"Reducing trainee mistakes. Better performance with changing to a high-fidelity simulation system?","authors":"Aino Ritva Weyers ,&nbsp;Gabriel von Waldenfels MD ,&nbsp;Pimrapat Gebert PhD ,&nbsp;Wolfgang Henrich MD, PhD ,&nbsp;Larry Hinkson MBBS, MD, MRCOG, FRCOG","doi":"10.1016/j.xagr.2024.100326","DOIUrl":"https://doi.org/10.1016/j.xagr.2024.100326","url":null,"abstract":"<div><h3>BACKGROUND</h3><p>Postpartum hemorrhage is a significant cause of both maternal morbidity and mortality worldwide and is increasing in incidence. This study aimed to assess improvement and identify shortcomings in trainee performance in different simulation systems in the management of postpartum hemorrhage.</p></div><div><h3>OBJECTIVE</h3><p>To perform a pilot study evaluating and comparing high- and low-fidelity simulation models, assessing improvement in repeated performance with high-fidelity mode and identifying mistakes made assessed using Objective Structured Assessment of Technical Skills and thereby exploring what aspects of emergency management of postpartum hemorrhage should be prioritized in teaching settings and assessing what simulation setup is most effective in achieving competence.</p></div><div><h3>STUDY DESIGN</h3><p>This was a prospective randomized, single-blinded, single-institution trial in a population of 17 junior obstetrical trainees at the Charité University Hospital Obstetric Simulation Center in Berlin. Trainees were randomized into 2 groups, with either initial low-fidelity simulation or high-fidelity simulation, followed by repeated assessment of performance, using the high-fidelity model simulation system. Individual simulation sessions were video-recorded and transcribed, and the timing of interventions was documented. Strandardized Objective Structured Assessment of Technical Skills forms were used as a checklist for performance.</p></div><div><h3>RESULTS</h3><p>There was a statistically significant general improvement in performance (<em>P</em>=.02; 24.7–27.2 of 31.0 points; average of 8.7%) in the second cycle of simulation assessment and a statistically significant training effect (<em>P</em>=.043; 24.4–28.4 of 31.0 points; average of 12.9%) in the group that underwent repeat simulation assessment from the initial low-fidelity system to the high-fidelity system compared with the group using the same high-fidelity setup (<em>P</em>=.276; 25.0–25.8 of 31.0; average of 2.4%).</p></div><div><h3>CONCLUSION</h3><p>There was an improvement in the performance when trainees underwent a repeated cycle of simulation assessment changing from a low-fidelity system to a high-fidelity system. Simulation assessment can identify mistakes and learning gaps that are important for obstetrical trainees. This study found that trainees make the same mistakes, regardless of which simulation model was initially used.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000200/pdfft?md5=49f5c837fc40d3c787d1a2f3d2d66b30&pid=1-s2.0-S2666577824000200-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140141463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with early readmission for postpartum hypertension 与产后高血压提前再入院相关的因素
Pub Date : 2024-02-28 DOI: 10.1016/j.xagr.2024.100323
Katherine Pressman MD , Jody Wellcome MD , Chandni Pooran BS , Daniela Crousillat MD , Mary A. Cain MD , Judette M. Louis MD

BACKGROUND

Hypertensive disorders of pregnancy are increasing in prevalence and a leading cause of early postpartum readmissions. Stricter blood pressure target goals for treatment of hypertension during pregnancy have recently been proposed, however, the treatment goals for management of postpartum hypertension are less well established.

OBJECTIVE

We sought to evaluate the clinical factors associated with early postpartum readmissions for hypertensive disease and to evaluate blood pressure thresholds associated with these readmissions.

STUDY DESIGN

We conducted a retrospective cohort study of women delivering at a tertiary care center between January 2018 and May 2022 who experienced a hospital readmission for postpartum hypertension or new onset postpartum preeclampsia. Charts were reviewed for clinical and sociodemographic data. Patients with early readmission (<72 hours after discharge) were compared with patients readmitted after 3 days of initial discharge. Data were analyzed using chi-square, Student t test, Mann-Whitney U test, and logistic regression where appropriate. The P value <.05 was considered significant.

RESULTS

During the study period, 23,372 deliveries occurred. Postpartum readmission due to worsening of a known diagnosis of hypertension or new onset postpartum preeclampsia occurred in 1.1% and 0.49% respectively. Patients with early readmission were more likely to have hypertensive disorders of pregnancy as the indication for delivery. Among patients readmitted, 93% had 2 or more systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg, and 73% had blood pressure of either systolic between 130 and 139 mmHg or diastolic between 80 and 89 mmHg within 24 hours before initial discharge. Only 27 patients met criteria (blood pressure ≥160/110 mmHg on >1 vitals check during their hospitalization) to be started on antihypertensives before initial delivery discharge; of those 25 (93%) were discharged with a new prescription for an antihypertensive. After controlling for confounding variables, predischarge blood pressure between 130–140 mmHg/80–90 mmHg (adjusted odds ratio, 2.4 [1.5–4.0]) was associated with an increased likelihood of early readmission.

CONCLUSION

Patients with delivery for hypertensive disorders of pregnancy and predischarge blood pressure ≥140/90 mmHg were less likely to have an early readmission within 3 days of initial discharge, however, patients with predischarge blood pressure 130–139 mmHg/80–89 mmHg were more likely to have an early readmission for hypertensive disorders of pregnancy and postpartum preeclampsia. Further research is indicated to evaluate interventions to prevent postpartum readmission in patients at high risk for persistent hypertension or new onset postpartum preeclampsia.

背景妊娠期高血压疾病的发病率越来越高,是产后早期再入院的主要原因之一。最近提出了更严格的妊娠期高血压治疗目标血压,但是,产后高血压的治疗目标还没有得到很好的确定。目的我们试图评估与产后早期高血压再入院相关的临床因素,并评估与这些再入院相关的血压阈值。研究设计我们对 2018 年 1 月至 2022 年 5 月期间在一家三级医疗中心分娩、因产后高血压或新发产后子痫前期而再次入院的产妇进行了回顾性队列研究。对病历中的临床和社会人口学数据进行了审查。将早期再入院(出院后 72 小时)的患者与首次出院 3 天后再入院的患者进行比较。在适当的情况下,使用卡方检验、学生 t 检验、曼-惠特尼 U 检验和逻辑回归分析数据。结果在研究期间,共有 23 372 例分娩。因已知高血压诊断恶化或新发产后子痫前期而再次入院的比例分别为 1.1%和 0.49%。提前再次入院的患者更有可能以妊娠高血压疾病作为分娩指征。在再次入院的患者中,93%的患者在初次出院前24小时内有2次或2次以上收缩压≥140毫米汞柱或舒张压≥90毫米汞柱,73%的患者在初次出院前24小时内收缩压在130至139毫米汞柱之间或舒张压在80至89毫米汞柱之间。只有 27 名患者符合在初次分娩出院前开始服用降压药的标准(在住院期间的一次生命体征检查中血压≥160/110 mmHg);其中 25 人(93%)在出院时获得了新的降压药处方。在控制了混杂变量后,出院前血压在 130-140 mmHg/80-90 mmHg 之间(调整后的几率比为 2.4 [1.5-4.0])与提前再入院的可能性增加有关。结论因妊娠高血压疾病而分娩且出院前血压≥140/90 mmHg的患者在首次出院后 3 天内再次入院的可能性较小,但出院前血压为 130-139 mmHg/80-89 mmHg 的患者因妊娠高血压疾病和产后子痫前期再次入院的可能性较大。有必要开展进一步研究,以评估对持续高血压或新发产后子痫前期高危患者采取干预措施以预防产后再入院的可能性。
{"title":"Factors associated with early readmission for postpartum hypertension","authors":"Katherine Pressman MD ,&nbsp;Jody Wellcome MD ,&nbsp;Chandni Pooran BS ,&nbsp;Daniela Crousillat MD ,&nbsp;Mary A. Cain MD ,&nbsp;Judette M. Louis MD","doi":"10.1016/j.xagr.2024.100323","DOIUrl":"https://doi.org/10.1016/j.xagr.2024.100323","url":null,"abstract":"<div><h3>BACKGROUND</h3><p>Hypertensive disorders of pregnancy are increasing in prevalence and a leading cause of early postpartum readmissions. Stricter blood pressure target goals for treatment of hypertension during pregnancy have recently been proposed, however, the treatment goals for management of postpartum hypertension are less well established.</p></div><div><h3>OBJECTIVE</h3><p>We sought to evaluate the clinical factors associated with early postpartum readmissions for hypertensive disease and to evaluate blood pressure thresholds associated with these readmissions.</p></div><div><h3>STUDY DESIGN</h3><p>We conducted a retrospective cohort study of women delivering at a tertiary care center between January 2018 and May 2022 who experienced a hospital readmission for postpartum hypertension or new onset postpartum preeclampsia. Charts were reviewed for clinical and sociodemographic data. Patients with early readmission (&lt;72 hours after discharge) were compared with patients readmitted after 3 days of initial discharge. Data were analyzed using chi-square, Student <em>t</em> test, Mann-Whitney <em>U</em> test, and logistic regression where appropriate. The <em>P</em> value &lt;.05 was considered significant.</p></div><div><h3>RESULTS</h3><p>During the study period, 23,372 deliveries occurred. Postpartum readmission due to worsening of a known diagnosis of hypertension or new onset postpartum preeclampsia occurred in 1.1% and 0.49% respectively. Patients with early readmission were more likely to have hypertensive disorders of pregnancy as the indication for delivery. Among patients readmitted, 93% had 2 or more systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg, and 73% had blood pressure of either systolic between 130 and 139 mmHg or diastolic between 80 and 89 mmHg within 24 hours before initial discharge. Only 27 patients met criteria (blood pressure ≥160/110 mmHg on &gt;1 vitals check during their hospitalization) to be started on antihypertensives before initial delivery discharge; of those 25 (93%) were discharged with a new prescription for an antihypertensive. After controlling for confounding variables, predischarge blood pressure between 130–140 mmHg/80–90 mmHg (adjusted odds ratio, 2.4 [1.5–4.0]) was associated with an increased likelihood of early readmission.</p></div><div><h3>CONCLUSION</h3><p>Patients with delivery for hypertensive disorders of pregnancy and predischarge blood pressure ≥140/90 mmHg were less likely to have an early readmission within 3 days of initial discharge, however, patients with predischarge blood pressure 130–139 mmHg/80–89 mmHg were more likely to have an early readmission for hypertensive disorders of pregnancy and postpartum preeclampsia. Further research is indicated to evaluate interventions to prevent postpartum readmission in patients at high risk for persistent hypertension or new onset postpartum preeclampsia.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000170/pdfft?md5=646a88d2cedca5296f68faf50644b69c&pid=1-s2.0-S2666577824000170-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140104046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of fibrin sealant patch to the disrupted lower uterine segment during surgery for placenta accreta spectrum 在胎盘早剥手术中使用纤维蛋白封堵贴膜修补被破坏的子宫下段图谱
Pub Date : 2024-02-26 DOI: 10.1016/j.xagr.2024.100327
Hadi Erfani MD, MPH , Andrew Vallejo MD, MS , Koji Matsuo MD, PhD
{"title":"Use of fibrin sealant patch to the disrupted lower uterine segment during surgery for placenta accreta spectrum","authors":"Hadi Erfani MD, MPH ,&nbsp;Andrew Vallejo MD, MS ,&nbsp;Koji Matsuo MD, PhD","doi":"10.1016/j.xagr.2024.100327","DOIUrl":"https://doi.org/10.1016/j.xagr.2024.100327","url":null,"abstract":"","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000212/pdfft?md5=478c504997cf6b95984ec98508bdbd8d&pid=1-s2.0-S2666577824000212-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140104047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between socioeconomic status and perinatal outcomes in in vitro fertilization conceptions 社会经济地位与体外受精受孕围产期结果之间的关系
Pub Date : 2024-02-23 DOI: 10.1016/j.xagr.2024.100329
Misha Fotovati DEC , Ahmad M. Badeghiesh MD, MPH , Haitham A. Baghlaf MD, MPH, RDMS , Michael H. Dahan MD

BACKGROUND

In vitro fertilization is the most used assisted reproductive technology in the United States that is increasing in efficiency and in demand. Certain states have mandated coverage that enable individuals with low income to undergo in vitro fertilization treatment.

OBJECTIVE

This study aimed to evaluate if socioeconomic status has an impact on the perinatal outcomes in in vitro fertilization pregnancies. We hypothesized that with greater coverage there may be an alleviation of the financial burden of in vitro fertilization that can facilitate the application of evidence-based practices.

STUDY DESIGN

This was a retrospective, population-based, observational study that was conducted in accordance with the Healthcare Cost and Utilization Project–Nationwide Inpatient Sample database over the 6-year period from 2008 to 2014 during which period 10,000 in vitro fertilization deliveries were examined. Maternal outcomes of interest included preterm prelabor rupture of membranes, preterm birth (ie, before 37 weeks of gestation), placental abruption, cesarean delivery, operative vaginal delivery, spontaneous vaginal delivery, maternal infection, chorioamnionitis, hysterectomy, and postpartum hemorrhage. Neonatal outcomes included small for gestational age neonates, defined as birthweight <10th percentile, intrauterine fetal death, and congenital anomalies.

RESULTS

Our study found that the socioeconomic status did not have a statistically relevant effect on the perinatal outcomes among women who underwent in vitro fertilization to conceive after adjusting for the potential confounding effects of maternal demographic, preexisting clinical characteristics, and comorbidities.

CONCLUSION

The literature suggests that in states with mandated in vitro fertilization coverage, there are better perinatal outcomes because, in part, of the increased use of best in vitro fertilization practices, such as single-embryo transfers. Moreover, the quality of medical care in states with coverage is in the highest quartile in the country. Therefore, our findings of equivalent perinatal outcomes in in vitro fertilization care irrespective of socioeconomic status possibly suggests that a lack of access to quality medical care may be a factor in the health disparities usually seen among individuals with lower socioeconomic status.

背景体外受精是美国最常用的辅助生殖技术,其效率和需求都在不断提高。本研究旨在评估社会经济状况是否会对体外受精妊娠的围产期结果产生影响。我们假设,随着覆盖面的扩大,体外受精的经济负担可能会减轻,从而促进循证实践的应用。研究设计这是一项基于人群的回顾性观察研究,根据医疗成本与利用项目--全国住院病人抽样数据库进行,时间跨度为2008年至2014年,为期6年,在此期间对10,000例体外受精分娩进行了研究。孕产妇的相关结果包括产前胎膜早破、早产(即妊娠 37 周前)、胎盘早剥、剖宫产、手术阴道分娩、自然阴道分娩、孕产妇感染、绒毛膜羊膜炎、子宫切除和产后出血。结果我们的研究发现,在对产妇人口统计学、既往临床特征和合并症的潜在混杂影响进行调整后,社会经济状况对接受体外受精受孕的妇女的围产期结局没有统计学意义上的影响。结论 文献表明,在强制实施体外受精的州,围产期结果较好,部分原因是采用了更多的最佳体外受精方法,如单胚胎移植。此外,在有医疗保险的州,医疗质量也处于全国最高的四分之一。因此,我们的研究结果表明,无论社会经济地位如何,体外受精治疗的围产期结果都是相同的,这可能表明,缺乏获得优质医疗服务的机会可能是导致社会经济地位较低的人之间出现健康差异的一个因素。
{"title":"The relationship between socioeconomic status and perinatal outcomes in in vitro fertilization conceptions","authors":"Misha Fotovati DEC ,&nbsp;Ahmad M. Badeghiesh MD, MPH ,&nbsp;Haitham A. Baghlaf MD, MPH, RDMS ,&nbsp;Michael H. Dahan MD","doi":"10.1016/j.xagr.2024.100329","DOIUrl":"https://doi.org/10.1016/j.xagr.2024.100329","url":null,"abstract":"<div><h3>BACKGROUND</h3><p>In vitro fertilization is the most used assisted reproductive technology in the United States that is increasing in efficiency and in demand. Certain states have mandated coverage that enable individuals with low income to undergo in vitro fertilization treatment.</p></div><div><h3>OBJECTIVE</h3><p>This study aimed to evaluate if socioeconomic status has an impact on the perinatal outcomes in in vitro fertilization pregnancies. We hypothesized that with greater coverage there may be an alleviation of the financial burden of in vitro fertilization that can facilitate the application of evidence-based practices.</p></div><div><h3>STUDY DESIGN</h3><p>This was a retrospective, population-based, observational study that was conducted in accordance with the Healthcare Cost and Utilization Project–Nationwide Inpatient Sample database over the 6-year period from 2008 to 2014 during which period 10,000 in vitro fertilization deliveries were examined. Maternal outcomes of interest included preterm prelabor rupture of membranes, preterm birth (ie, before 37 weeks of gestation), placental abruption, cesarean delivery, operative vaginal delivery, spontaneous vaginal delivery, maternal infection, chorioamnionitis, hysterectomy, and postpartum hemorrhage. Neonatal outcomes included small for gestational age neonates, defined as birthweight &lt;10th percentile, intrauterine fetal death, and congenital anomalies.</p></div><div><h3>RESULTS</h3><p>Our study found that the socioeconomic status did not have a statistically relevant effect on the perinatal outcomes among women who underwent in vitro fertilization to conceive after adjusting for the potential confounding effects of maternal demographic, preexisting clinical characteristics, and comorbidities.</p></div><div><h3>CONCLUSION</h3><p>The literature suggests that in states with mandated in vitro fertilization coverage, there are better perinatal outcomes because, in part, of the increased use of best in vitro fertilization practices, such as single-embryo transfers. Moreover, the quality of medical care in states with coverage is in the highest quartile in the country. Therefore, our findings of equivalent perinatal outcomes in in vitro fertilization care irrespective of socioeconomic status possibly suggests that a lack of access to quality medical care may be a factor in the health disparities usually seen among individuals with lower socioeconomic status.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000236/pdfft?md5=1ca9aa24dfba3537ce5549af9eeb0e8b&pid=1-s2.0-S2666577824000236-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140104043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-dose buprenorphine initiation during pregnancy: a case report 妊娠期低剂量丁丙诺啡诱导:病例报告
Pub Date : 2024-02-01 DOI: 10.1016/j.xagr.2024.100308
Shivania Reddy BSc , Caitlin E. Martin MD, MPH, FACOG, FASAM

Buprenorphine is recommended for pregnant patients with opioid use disorder. Traditional buprenorphine initiation requires moderate withdrawal symptoms to prevent precipitating withdrawal. Low-dose buprenorphine initiation is newly emerging and does not require withdrawal prior to initiation.

Case 1 is a 30-year-old pregnant patient with opioid use disorder. Inpatient rapid buprenorphine initiation precipitated withdrawal. Low-dose buprenorphine initiation was started twice, 1 outpatient and 1 inpatient with nonprescribed opioid use between. Case 2 is a 28-year-old pregnant patient with opioid use disorder. The patient started an inpatient low-dose buprenorphine initiation and planned its completion at home after discharge. Neither patient experienced precipitated withdrawal during their low-dose initiations.

These buprenorphine initiations in pregnant patients guided by a low-dose initiations protocol using only split buprenorphine-naloxone films represent an alternative opioid use disorder treatment method with potentially high acceptability. Future work is warranted to advance the evidence base informing clinicians on how to optimally individualize buprenorphine initiations in pregnancy.

建议患有阿片类药物使用障碍的孕妇使用丁丙诺啡。传统的丁丙诺啡起始治疗需要适度的戒断症状,以防止诱发戒断。低剂量丁丙诺啡是一种新兴药物,使用前不需要出现戒断症状。病例 1 是一名患有阿片类药物使用障碍的 30 岁孕妇。住院病人快速服用丁丙诺啡会导致戒断。低剂量丁丙诺啡起始治疗进行了两次,一次是门诊患者,一次是住院病人,中间间隔了非处方阿片类药物的使用。病例 2 是一名 28 岁的怀孕患者,患有阿片类药物使用障碍。患者在住院期间开始服用低剂量丁丙诺啡,并计划出院后在家中完成。在仅使用丁丙诺啡-纳洛酮分片的低剂量启动方案指导下,怀孕患者开始服用丁丙诺啡,这代表了一种替代性阿片类药物使用障碍治疗方法,具有潜在的高可接受性。未来的工作需要推进证据基础,为临床医生提供关于如何在妊娠期最佳地个体化启动丁丙诺啡的信息。
{"title":"Low-dose buprenorphine initiation during pregnancy: a case report","authors":"Shivania Reddy BSc ,&nbsp;Caitlin E. Martin MD, MPH, FACOG, FASAM","doi":"10.1016/j.xagr.2024.100308","DOIUrl":"10.1016/j.xagr.2024.100308","url":null,"abstract":"<div><p>Buprenorphine is recommended for pregnant patients with opioid use disorder. Traditional buprenorphine initiation requires moderate withdrawal symptoms to prevent precipitating withdrawal. Low-dose buprenorphine initiation is newly emerging and does not require withdrawal prior to initiation.</p><p>Case 1 is a 30-year-old pregnant patient with opioid use disorder. Inpatient rapid buprenorphine initiation precipitated withdrawal. Low-dose buprenorphine initiation was started twice, 1 outpatient and 1 inpatient with nonprescribed opioid use between. Case 2 is a 28-year-old pregnant patient with opioid use disorder. The patient started an inpatient low-dose buprenorphine initiation and planned its completion at home after discharge. Neither patient experienced precipitated withdrawal during their low-dose initiations.</p><p>These buprenorphine initiations in pregnant patients guided by a low-dose initiations protocol using only split buprenorphine-naloxone films represent an alternative opioid use disorder treatment method with potentially high acceptability. Future work is warranted to advance the evidence base informing clinicians on how to optimally individualize buprenorphine initiations in pregnancy.</p></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666577824000029/pdfft?md5=80bd4c3bf2d97421a66b18315b2d60e2&pid=1-s2.0-S2666577824000029-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139638227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal Mortality Review Committee findings: awareness and recommended dissemination strategies in Arkansas 孕产妇死亡率审查委员会的调查结果:阿肯色州的认识和建议传播策略
Pub Date : 2024-02-01 DOI: 10.1016/j.xagr.2023.100306
Jennifer Callaghan-Koru PhD, Tanvangi Tiwari MPP, Dawn Brown MSN, RNC-ONQS, Nirvana Manning MD, William Greenfield MD
{"title":"Maternal Mortality Review Committee findings: awareness and recommended dissemination strategies in Arkansas","authors":"Jennifer Callaghan-Koru PhD,&nbsp;Tanvangi Tiwari MPP,&nbsp;Dawn Brown MSN, RNC-ONQS,&nbsp;Nirvana Manning MD,&nbsp;William Greenfield MD","doi":"10.1016/j.xagr.2023.100306","DOIUrl":"10.1016/j.xagr.2023.100306","url":null,"abstract":"","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266657782300148X/pdfft?md5=2857002fe596de9dbf3982821c98734f&pid=1-s2.0-S266657782300148X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139454972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
AJOG global reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1